If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Product Launch » Re-launch
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Non-members: Click here to sign-up for a complimentary tour of
"Product Re-Launch Success: Key Findings"
Re-launching a pharmaceutical product is a marketing challenge that no brand executive wants to face, but many often do. With millions of dollars poured into the development and marketing of products, companies are loathe to give up their initial investment, but they also are hesitant to waste further resources to correct mistakes. This five-page document summarizes for brand executives major key findings and insights on re-launching pharmaceutical products.
Consumer Products; Diagnostic; Pharmaceutical; Medical Device; Biotech; Health Care
Bayer Healthcare; UCB Pharma; Schering-Plough; Roche; Pfizer; Novartis; Merck; AstraZeneca; DSM Pharmaceutical; Sanofi-aventis; Abbott Laboratories; Eli Lilly; GlaxoSmithKline l